STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Owens & Minor, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Positive)
Form Type
4

Rhea-AI Filing Summary

Coliseum Capital affiliates reported multiple open-market purchases of Owens & Minor, Inc. (OMI) common stock between 08/12/2025 and 08/14/2025. The filings show purchases of 720,000, 325,000 and 492,852 shares at weighted-average prices of $5.15, $5.46 and $5.31, respectively. After these transactions the reporting persons beneficially owned 13,100,807 shares in the aggregate, held indirectly through Coliseum Capital Partners, L.P. and a separate advisory account; footnotes state CCP directly owned 10,657,337 shares and the Separate Account 2,443,470 shares. No derivative securities were reported.

Positive

  • Material accumulation of OMI shares over three days increasing aggregate indirect ownership to 13,100,807 shares
  • Transparent disclosure including weighted-average prices and footnotes specifying direct holdings of CCP and the Separate Account
  • No derivatives reported, indicating purchases were straight common stock acquisitions

Negative

  • None.

Insights

TL;DR Coliseum Capital materially increased its stake in OMI to 13.1M shares via multiple purchases at ~$5.15–$5.46.

The Form 4 discloses concentrated, open-market accumulation over three days, raising aggregate indirect ownership to 13,100,807 shares. The reported weighted-average purchase prices range from $5.15 to $5.46, with execution in multiple transactions. These purchases are recorded as indirect holdings through Coliseum Capital Partners and a separate advisory account, and the filing includes standard disclaimers of beneficial ownership except for pecuniary interest. No options or other derivatives were reported.

TL;DR Reporting persons are managers/owners of the adviser and disclosed indirect ownership; filings include required footnotes and signatures.

The filing identifies Coliseum Capital Management, Coliseum Capital, LLC, Coliseum Capital Partners, Christopher Shackelton and Adam Gray as reporting persons and explains the chain of ownership and the disclaimers. Signatures and footnotes provide transparency on ownership allocation between CCP and a separate account. The disclosure appears procedurally complete and does not report any derivative holdings or plan-based trades.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Coliseum Capital Management, LLC

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OWENS & MINOR INC/VA/ [ OMI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $2 per share ("Common Stock") 08/12/2025 P 720,000 A $5.15(1) 12,282,955 I See Footnotes(2)(3)
Common Stock 08/13/2025 P 325,000 A $5.46(4) 12,607,955 I See Footnotes(2)(3)
Common Stock 08/14/2025 P 492,852 A $5.31(5) 13,100,807 I See Footnotes(2)(3)(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Coliseum Capital Management, LLC

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Shackelton Christopher S

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Coliseum Capital, LLC

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
COLISEUM CAPITAL PARTNERS, L.P.

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Gray Adam

(Last) (First) (Middle)
105 ROWAYTON AVE.

(Street)
ROWAYTON CT 06853

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $5.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
2. The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser; and (b) a separate account investment advisory client of CCM (the "Separate Account").
3. Christopher S. Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.00 to $5.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
6. Following the transactions reported herein, CCP directly owned 10,657,337 shares of Common Stock and the Separate Account directly owned 2,443,470 shares of Common Stock.
Coliseum Capital Management, LLC, By: /s/ Ash Cousins, Attorney-in-fact, Ash Cousins, Attorney-in-fact 08/14/2025
Christopher Shackelton, By: /s/ Ash Cousins, Attorney-in-fact, Ash Cousins, Attorney-in-fact 08/14/2025
Coliseum Capital, LLC, By: /s/ Ash Cousins, Attorney-in-fact, Ash Cousins, Attorney-in-fact 08/14/2025
Coliseum Capital Partners, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Ash Cousins, Attorney-in-fact, Ash Cousins, Attorney-in-fact 08/14/2025
Adam Gray, By: /s/ Ash Cousins, Attorney-in-fact, Ash Cousins, Attorney-in-fact 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Coliseum Capital report for OMI?

They reported open-market purchases of 720,000, 325,000, and 492,852 OMI shares on 08/12/2025, 08/13/2025, and 08/14/2025, respectively.

What prices were paid for the OMI shares?

Reported weighted-average prices were $5.15 for the 08/12 trades, $5.46 for 08/13, and $5.31 for 08/14; each range was purchased at multiple prices within disclosed ranges.

How many OMI shares do Coliseum affiliates beneficially own after these trades?

The filing states aggregate beneficial ownership of 13,100,807 shares, comprised of 10,657,337 shares held by CCP and 2,443,470 by a separate account.

Were any derivative securities reported in this Form 4?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned following these transactions.

Who are the reporting persons named in the filing?

Reporting persons include Coliseum Capital Management, LLC, Coliseum Capital, LLC, Coliseum Capital Partners, L.P., and individual managers Christopher S. Shackelton and Adam Gray.
Owens & Minor

NYSE:OMI

OMI Rankings

OMI Latest News

OMI Latest SEC Filings

OMI Stock Data

212.70M
74.52M
3.44%
100.24%
11.91%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
GLEN ALLEN